FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 Hina Zahid7 Jun 2021 2:00 AM GMTToday, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with ...
Semaglutide Resolves Nonalcoholic steatohepatitis, Finds Study Dr Kartikeya Kohli3 April 2021 6:30 AM GMTNonalcoholic steatohepatitis (NASH) is a common disease that is associated with increased morbidity and mortality, but treatment options are limited....
Semaglutide with intensive behavioral therapy causes significant weight loss in obese: JAMA Medha25 Feb 2021 12:30 AM GMTUSA: Once-weekly subcutaneous semaglutide paired with intensive behavioral therapy and initial low-calorie diet resulted in triple weight loss as...
Semaglutide may effect weight loss upto 20% in obese: NEJM Medha12 Feb 2021 6:15 AM GMTUK: Once-weekly semaglutide (2.4 mg) in adjunct with diet and exercise, is effective for weight loss in non-diabetic obese or overweight adults, finds ...
Semaglutide reduces major adverse CV event risk in Diabetics with raised triglycerides MD Bureau1 Jan 2021 11:45 AM GMTA posthoc analysis on SUSTAIN 6 and PIONEER 6 trial showed semaglutide was associated with consistent reduction in major Adverse cardiovascular event...
Semaglutide to be sold only on prescription of Endocrinologist, PG Medicine in India: CDSCO Committee Farhat Nasim22 Dec 2020 11:28 AM GMTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has call...
Oral semaglutide leads to weight loss by improving eating control in diabetics: Study Medha18 Dec 2020 5:45 AM GMTDenmark: Patients with type 2 diabetes (T2D) taking oral semaglutide for 12 weeks had lower energy intake resulting in reduced body fat mass,...
Semaglutide shows promise in patients with nonalcoholic steatohepatitis: NEJM Dr Satabdi Saha18 Nov 2020 12:30 PM GMTAccording to the findings of a recently published study in New England Journal of Medicine, treatment with semaglutide resulted in a significantly...
Semaglutide tied to significant weight loss when added to intensive behavioral therapy Hina Zahid10 Nov 2020 9:15 AM GMTPLAINSBORO, N.J. -Researchers have found in a new phase 3a trial that Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo ...
Semaglutide effectively manages blood sugar and kidney function in diabetes: Lancet Dr Satabdi Saha28 Sep 2020 6:30 AM GMTPatients with type 2 diabetes have increased risk of developing chronic kidney disease. Researchers conducted a study to examine the effects of...
Type 2 diabetes: Semaglutide significantly reduces blood sugar and body weight Medha16 July 2020 5:30 AM GMTCanada: Initiation of semaglutide therapy in type 2 diabetes (T2D) patients naive to GLP-1 RA therapy helped in a significant reduction of...
